Latest Articles
Two gynecologists punished for research misconduct - China Daily
Two gynecologists punished for research misconduct China Daily
Published: May 7, 2025, 12:28 p.m.
Meet ESPN’s Molly Qerim, who uses her platform to support important causes - South China Morning Post
Meet ESPN’s Molly Qerim, who uses her platform to support important causes South China Morning Post
Published: April 17, 2025, 10 a.m.
Knowledge and awareness of endometriosis among women in Southwest China: a cross-sectional study.
Endometriosis is a prevalent yet under-recognized gynecological condition that significantly impacts women's quality of life. Despite its burden, data on the knowledge and awareness of endometriosis among women in Southwest …
Published: March 12, 2025, midnight
China’s govt rolls out incentives to boost consumer spending, stimulate economic growth - Townsville Bulletin
China’s govt rolls out incentives to boost consumer spending, stimulate economic growth Townsville Bulletin
Published: Feb. 13, 2025, 6:45 a.m.
A hospital in China has posted anti-abortion posters without scientific grounds, causing outrage the.. - 매일경제
A hospital in China has posted anti-abortion posters without scientific grounds, causing outrage the.. 매일경제
Published: Jan. 13, 2025, 12:39 p.m.
World Health Organisation urges China to share COVID-19 origins data amid five-year milestone - Head Topics
World Health Organisation urges China to share COVID-19 origins data amid five-year milestone Head Topics
Published: Dec. 31, 2024, 5:12 a.m.
The Microbiome Landscape of Adenomyosis: A Systematic Review.
Alterations in the microbiome composition have been identified in common gynecologic pathologies such as endometriosis carving a new frontier in diagnosis and treatment. We aimed to examine the existing literature …
Published: Dec. 20, 2024, midnight
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | IVBIY Stock News - StockTitan
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | IVBIY Stock News StockTitan
Published: Dec. 4, 2024, 12:01 a.m.
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | HCM Stock News - StockTitan
Innovent & HUTCHMED Win China Approval for Breakthrough Endometrial Cancer Therapy | HCM Stock News StockTitan
Published: Dec. 4, 2024, midnight
Hutchmed endometrial cancer treatment gets conditional approval in China - ShareCast
Hutchmed endometrial cancer treatment gets conditional approval in China ShareCast
Published: Dec. 3, 2024, 10:28 a.m.
Link copied to clipboard!